Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!
includes T2-T3 lesions, or metastatic bladder cancer (MBC) [2]. Conservative treatment for NMIBC generally includes a partial or full transurethral resection of the bladder tumor in combination ...
antibody immunotherapy agent and can be used as a co-immune checkpoint inhibitor in the treatment of advanced or metastatic bladder cancer [19]. Programmed cell death ligand 1 (PD-L1) related genes are also ...
that assign claudin-low subtype in human iUC Hierarchical clustering of bladder tumors using a list of genes that was previously utilized to define claudin-low tumors in human breast cancer patients, confirmed ...
understanding of the genetic factors involved in adaptation to the pathophysiological consequences of As exposure. arsenic, positive selection, bladder cancer , Native Americans Introduction Inorganic arsenic ...
. Methods Primary tumors from 102 patients with comparable treatment from the LMU Munich (n = 37), the University Hospital Düsseldorf (n = 33), and The Cancer Genome Atlas (n = 32) were included. Risk groups ...
, bacterial, fungal and parasitic) signatures associated with prostate cancer , which may provide diagnostic and prognostic information that may guide treatment strategies. Three distinct microbiome signatures ...
-like subtypes and derived the BASE47 ( Bladder cancer Analysis of Subtype by gene Expression) RNA expression classifier to characterize the molecular subtype of patient tumors [5]. Molecular ...
( Adapted from [31]). Complex stage-specific interventions in MAPK pathway to disrupt proliferative signalling in bladder cancer The idea of an SL treatment approach is to take advantage of the peculiarities ...
cancer therapies, for a period of seven days is sufficient to detect treatment -induced changes in gene expression. By examining whole body transcriptome responses we provide a novel route toward gene ...
integrative approach to cancer management promises to provide unparalleled ability to assess risk , target therapies, and tailor treatments throughout the disease course. Figure 1. Open in new tabDownload slide ...
Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!